NASDAQ:VYNE
Vyne Therapeutics Inc Stock News
$2.77
+0.0700 (+2.59%)
At Close: May 17, 2024
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
12:45pm, Thursday, 07'th Apr 2022
VYNE Therapeutics Inc (NASDAQ: VYNE) announced positive efficacy results from the Phase 1b segment of Phase 1b/2a trial of FMX114 in mild-to-moderate atopic dermatitis (AD). Mean Atopic Dermatitis
VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis
11:43am, Wednesday, 30'th Mar 2022
VYNE Therapeutics Inc (NASDAQ: VYNE) announced positive preclinical data from its VYN201 program in the rheumatoid arthritis (RA) animal model. The Company will start a first-in-human trial for VYN
VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder
12:06pm, Monday, 07'th Mar 2022
VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disorder of the skin. In the preclinical model, pan-bro
VYNE Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
08:00am, Thursday, 03'rd Mar 2022
BRIDGEWATER, N.J., March 03, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and diffe
Vyne Therapeutics Stock (VYNE): Why The Price Substantially Fell Today
11:51am, Thursday, 13'th Jan 2022
The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) fell by over 13% during intraday trading today. This is why it happened.
VYNE Therapeutics Offloads Its Topical Minocycline Assets To Journey Medical In $450M+ Deal
08:38am, Thursday, 13'th Jan 2022
Journey Medical Corporation (NASDAQ: DERM) has acquired Molecule Stabilizing Technology (MST) franchise, including Amzeeq (minocycline) topical foam and Zilxi (minocycline) topical foam from VYNE Th
4 Penny Stocks That Are Trending on Reddit Right Now and Why
01:42pm, Thursday, 09'th Dec 2021
Are these Reddit penny stocks on your watchlist right now? The post 4 Penny Stocks That Are Trending on Reddit Right Now and Why appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
10 Penny Stocks To Buy In December According To Insiders
12:08pm, Tuesday, 07'th Dec 2021
Corporate insiders buy penny stocks & these 10 are getting purchased in December 2021. The post 10 Penny Stocks To Buy In December According To Insiders appeared first on Penny Stocks to Buy, Picks, N
Restaurant Stocks: What's Going on With TACO, DIN, CAKE, MCD, BJRI and FRGI Today?
12:06pm, Monday, 06'th Dec 2021
Restaurant stocks are on the move Monday and we're diving into today's news to give traders all the details on why that's happening. The post Restaurant Stocks: What's Going on With TACO, DIN, CAKE, M
VYNE Stock Price Predictions: Why One Analyst Sees VYNE Therapeutics Going to $7
11:45am, Monday, 06'th Dec 2021
VYNE Therapeutics (VYNE) stock price predictions are heating up on Monday with one analyst setting a high goal for the company to reach. The post VYNE Stock Price Predictions: Why One Analyst Sees VYN
5 Penny Stocks To Buy In December According To Insiders
10:43am, Monday, 06'th Dec 2021
Yes, even insiders buy penny stocks & here are 5 getting scooped up in December 2021. The post 5 Penny Stocks To Buy In December According To Insiders appeared first on Penny Stocks to Buy, Picks, New
Vyne Therapeutics Stock (VYNE): Why The Price Increased Today
07:49am, Monday, 06'th Dec 2021
The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) increased by over 9% pre-market today. This is why it happened.
VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
08:00am, Thursday, 18'th Nov 2021
BRIDGEWATER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q3 2021 results - Earnings Call Transcript
12:34pm, Wednesday, 10'th Nov 2021
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q3 2021 results - Earnings Call Transcript
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue Estimates
09:57am, Wednesday, 10'th Nov 2021
VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of -5.88% and -12.51%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the s